Jacky Luiten

12 | Chapter 1 References 1. Wilson JMG, G. J. Principles and Practice of Screening for Disease 1968. Available from: http://whqlibdoc.who.int/php/who_php_34.pdf. 2. Dowling EC, Klabunde C, Patnick J, Ballard‐Ba rbash R. Breast and cervical cancer screening programme implementation in 16 countries. J Me d Screen. 2010;17(3):139‐146. 3. Sankatsing VDV, van Ravesteyn NT, Heijnsdijk EAM, Looman CWN, van Luijt PA, Fracheboud J, et al. The effect of population‐based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow‐up. Int J Cancer. 2017;141(4):671‐677. 4. Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA. 1971;215(11):1777‐1785. 5. Advisory Committee on Breast Cancer S. Screening for breast cancer in England: past and future. J Med Screen. 2006;13(2):59‐61. 6. Fracheboud J, de Koning HJ, Boer R, Groenewoud JH, Verbeek AL, Broeders MJ, et al. Nationwide breast cancer screening programme fully implemented in The Netherlands. Breast (Edinburgh, Scotland). 2001;10(1):6‐11. 7. den Heeten GJ, Broeders MJ. Nationwide breast cancer screening in the Neth erlands. Medica Mudi. 2009;53(1):4. 8. IKNL. Monitor bevolkingsonderzoek [cited 2020 Jan]. Available from: https://www.iknl.nl/ getmedia/ 15bd0ea1‐eb30‐4647‐82b8‐12e11c3dbe9c/Monitor‐bevolkingson derzoek‐borstkanker‐ 017‐2018_IKNL.pdf. 9. Haus AG. Recent advances in screen‐film mammography. Radiol Clin North Am. 1987;25(5):913‐ 928. 10. Yaffe M, Boyd N. Mammographic breast density and cancer risk: the radiological view. Gynecol Endocrinol. 2005;21 Suppl 1:6‐11. 11. Jing H. YY, Wernick M.N., Yarusso L.M., Nishikawa R.M. A comparison study of image features between FFDM and film mammogram images. Med Phys. 2012;39(7):4386‐4394. 12. van Luijt PA, Fracheboud J, Heijnsdijk EA, den Heeten GJ, de Koning HJ, National Evaluation Team for Breast Cancer Screening in Netherlands Study G. Nation‐wide data on screening performance during the transition to digital mammography: observations in 6 million screens. Eur J Cancer. 2013;49(16):3517‐3525. 13. Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Breast Cancer Res. 2012;14(1):R10. 14. van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2009;115(1):181‐183. 15. Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI Screening for Women with Extremely Dense Breast Tissue. N Engl J Med. 2019;381(22):2091‐2102. 16. Jacklyn G, McGeechan K, Irwig L, Houssami N, Morrell S, Bell K, et al. Trends in stage‐specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography. Breast Cancer Res Treat. 2017;166(3):843‐854. 17. Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hubner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program2019 Nov 1; Int J Cancer. Epub ahead of print. 18. de Munck L, Fracheboud J, de Bock GH, den Heeten GJ, Siesling S, Broeders MJM. Is the incidence of advanced‐stage breast cancer affected by whether women attend a steady‐state screening program? Int J Cancer. 2018;143(4):842‐850. 19. Thomas ET, Del Mar C, Glasziou P, Wright G, Barratt A, Bell KJL. Prevalence of incidental breast cancer and precursor lesions in autopsy studies: a systematic review and meta‐analysis. BMC Cancer. 2017;17(1):808.